Add Yahoo as a preferred source to see more of our stories on Google. The Bayer Pharma AG logo is seen on April 03, 2025 in Berlin, Germany. (Maja Hitij via Getty Images) This story was originally ...

WASHINGTON—Donald Patrick McDonnell, Ph.D., has been awarded the Endocrine Society’s John D. Baxter Prize for Entrepreneurship for discovering hormone therapies for treating breast and prostate cancer ...

(Reuters) -AstraZeneca and Daiichi Sankyo's Enhertu slows the progression of breast cancer by about five months in women whose disease worsened after endocrine therapy - even if they had very low ...

CHICAGO -- The neurokinin-targeted agent elinzanetant significantly reduced the frequency of hot flashes among women receiving endocrine therapy for hormone receptor (HR)-positive breast cancer or its ...

(RTTNews) - Crinetics Pharmaceuticals Inc. (CRNX) is approaching a watershed moment in its corporate and clinical trajectory. On September 25, 2025, the FDA is expected to announce its decision on the ...

Adjuvant endocrine therapy is a long-term drug therapy prescribed to prevent recurrence of hormone receptor–positive breast cancer. Data on adjuvant endocrine therapy are reported though clinical ...

AstraZeneca and Daiichi Sankyo’s Enhertu slows the progression of breast cancer by about five months in women whose disease worsened after endocrine therapy – even if they had very low levels of the ...